

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 7.56120097 |
| 2 | doxorubicin metabolic process (GO:0044598) | 7.56120097 |
| 3 | daunorubicin metabolic process (GO:0044597) | 7.56120097 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.69405771 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.82277221 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.78556094 |
| 7 | primary alcohol catabolic process (GO:0034310) | 5.49669860 |
| 8 | bile acid and bile salt transport (GO:0015721) | 5.40092919 |
| 9 | sulfate transmembrane transport (GO:1902358) | 5.16325440 |
| 10 | response to nitrosative stress (GO:0051409) | 4.97854264 |
| 11 | phenol-containing compound catabolic process (GO:0019336) | 4.96822231 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 4.76672186 |
| 13 | desmosome organization (GO:0002934) | 4.63482683 |
| 14 | regulation of guanylate cyclase activity (GO:0031282) | 4.53211683 |
| 15 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.53032482 |
| 16 | viral transcription (GO:0019083) | 4.44062293 |
| 17 | ribosomal small subunit biogenesis (GO:0042274) | 4.37344059 |
| 18 | glycoside metabolic process (GO:0016137) | 4.36103797 |
| 19 | sulfate transport (GO:0008272) | 4.34161556 |
| 20 | quinone metabolic process (GO:1901661) | 4.33563189 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.33285531 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.33013067 |
| 23 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.24688573 |
| 24 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.24688573 |
| 25 | * cellular glucuronidation (GO:0052695) | 4.21711247 |
| 26 | * uronic acid metabolic process (GO:0006063) | 4.19123425 |
| 27 | * glucuronate metabolic process (GO:0019585) | 4.19123425 |
| 28 | translational termination (GO:0006415) | 4.17130008 |
| 29 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.12150445 |
| 30 | renal system process involved in regulation of blood volume (GO:0001977) | 4.10764408 |
| 31 | cyclooxygenase pathway (GO:0019371) | 4.08983970 |
| 32 | drug transmembrane transport (GO:0006855) | 4.08619772 |
| 33 | phospholipid efflux (GO:0033700) | 4.05306536 |
| 34 | respiratory burst (GO:0045730) | 4.02818365 |
| 35 | * flavonoid metabolic process (GO:0009812) | 3.99803986 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95533761 |
| 37 | gap junction assembly (GO:0016264) | 3.90508199 |
| 38 | response to peptidoglycan (GO:0032494) | 3.88311203 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.86905634 |
| 40 | angiotensin maturation (GO:0002003) | 3.85424123 |
| 41 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.84337759 |
| 42 | epoxygenase P450 pathway (GO:0019373) | 3.83658560 |
| 43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.81338276 |
| 44 | protein targeting to ER (GO:0045047) | 3.78532555 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.77038667 |
| 46 | cotranslational protein targeting to membrane (GO:0006613) | 3.75747977 |
| 47 | protein localization to endoplasmic reticulum (GO:0070972) | 3.71752524 |
| 48 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.64740024 |
| 49 | regulation of respiratory burst (GO:0060263) | 3.61030188 |
| 50 | ethanol oxidation (GO:0006069) | 3.58109238 |
| 51 | cranial nerve development (GO:0021545) | 3.57235446 |
| 52 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.55956588 |
| 53 | positive regulation of respiratory burst (GO:0060267) | 3.54139521 |
| 54 | glutathione biosynthetic process (GO:0006750) | 3.53717372 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.53239123 |
| 56 | * drug metabolic process (GO:0017144) | 3.52689887 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.52687360 |
| 58 | retinal ganglion cell axon guidance (GO:0031290) | 3.52675698 |
| 59 | glutathione derivative biosynthetic process (GO:1901687) | 3.46446588 |
| 60 | glutathione derivative metabolic process (GO:1901685) | 3.46446588 |
| 61 | intestinal absorption (GO:0050892) | 3.45674843 |
| 62 | regulation of vitamin metabolic process (GO:0030656) | 3.44778107 |
| 63 | O-glycan processing (GO:0016266) | 3.42509980 |
| 64 | translational elongation (GO:0006414) | 3.42112427 |
| 65 | intestinal cholesterol absorption (GO:0030299) | 3.41924976 |
| 66 | viral life cycle (GO:0019058) | 3.41815797 |
| 67 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.41259050 |
| 68 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.41259050 |
| 69 | endocrine process (GO:0050886) | 3.41259050 |
| 70 | intestinal epithelial cell development (GO:0060576) | 3.36758213 |
| 71 | oligosaccharide catabolic process (GO:0009313) | 3.36178470 |
| 72 | drug transport (GO:0015893) | 3.35786986 |
| 73 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.34857855 |
| 74 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.34123795 |
| 75 | ATP synthesis coupled proton transport (GO:0015986) | 3.34123795 |
| 76 | cellular protein complex disassembly (GO:0043624) | 3.32063450 |
| 77 | urea cycle (GO:0000050) | 3.31747514 |
| 78 | urea metabolic process (GO:0019627) | 3.31747514 |
| 79 | microglial cell activation (GO:0001774) | 3.30887043 |
| 80 | glucocorticoid biosynthetic process (GO:0006704) | 3.29393518 |
| 81 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.27887710 |
| 82 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.25371656 |
| 83 | bicarbonate transport (GO:0015701) | 3.23243864 |
| 84 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.20446297 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17019216 |
| 86 | ribosomal large subunit biogenesis (GO:0042273) | 3.15238226 |
| 87 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.15088257 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.14380854 |
| 89 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.13539735 |
| 90 | regulation of systemic arterial blood pressure (GO:0003073) | 3.10116001 |
| 91 | ethanol metabolic process (GO:0006067) | 3.09934283 |
| 92 | positive regulation of fatty acid oxidation (GO:0046321) | 3.09449882 |
| 93 | primary alcohol metabolic process (GO:0034308) | 3.08375999 |
| 94 | regulation of triglyceride catabolic process (GO:0010896) | 3.08230754 |
| 95 | parturition (GO:0007567) | 3.06970841 |
| 96 | nitrogen cycle metabolic process (GO:0071941) | 3.06509337 |
| 97 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.04583753 |
| 98 | lipoprotein metabolic process (GO:0042157) | 3.02994716 |
| 99 | cholesterol efflux (GO:0033344) | 3.02928553 |
| 100 | sulfur compound transport (GO:0072348) | 3.01656408 |
| 101 | cellular response to cadmium ion (GO:0071276) | 2.99510085 |
| 102 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.98669890 |
| 103 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.97069664 |
| 104 | cysteine metabolic process (GO:0006534) | 2.95524586 |
| 105 | protein-lipid complex remodeling (GO:0034368) | 2.95156006 |
| 106 | macromolecular complex remodeling (GO:0034367) | 2.95156006 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 2.95156006 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94634691 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94634691 |
| 110 | modulation by symbiont of host immune response (GO:0052553) | 2.94634691 |
| 111 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94634691 |
| 112 | modulation by symbiont of host defense response (GO:0052031) | 2.94634691 |
| 113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94634691 |
| 114 | neurotransmitter catabolic process (GO:0042135) | 2.93738516 |
| 115 | sulfur amino acid catabolic process (GO:0000098) | 2.93578032 |
| 116 | transcytosis (GO:0045056) | 2.92713728 |
| 117 | sperm capacitation (GO:0048240) | 2.92592752 |
| 118 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92052713 |
| 119 | reverse cholesterol transport (GO:0043691) | 2.91473630 |
| 120 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90836499 |
| 121 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.90715601 |
| 122 | plasma lipoprotein particle assembly (GO:0034377) | 2.90458203 |
| 123 | neurotransmitter biosynthetic process (GO:0042136) | 2.90155061 |
| 124 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.89885626 |
| 125 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.89770783 |
| 126 | reactive oxygen species biosynthetic process (GO:1903409) | 2.89476897 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.89061323 |
| 128 | cellular ketone body metabolic process (GO:0046950) | 2.88957121 |
| 129 | response to food (GO:0032094) | 2.88597776 |
| 130 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.88439542 |
| 131 | oligosaccharide biosynthetic process (GO:0009312) | 2.88155118 |
| 132 | one-carbon metabolic process (GO:0006730) | 2.87650560 |
| 133 | hormone catabolic process (GO:0042447) | 2.86276342 |
| 134 | high-density lipoprotein particle remodeling (GO:0034375) | 2.85543022 |
| 135 | superoxide anion generation (GO:0042554) | 2.85165383 |
| 136 | killing of cells of other organism (GO:0031640) | 2.82261006 |
| 137 | disruption of cells of other organism (GO:0044364) | 2.82261006 |
| 138 | macrophage activation (GO:0042116) | 2.82043894 |
| 139 | protein-lipid complex assembly (GO:0065005) | 2.81446375 |
| 140 | plasma lipoprotein particle clearance (GO:0034381) | 2.79422822 |
| 141 | citrulline biosynthetic process (GO:0019240) | 2.79275869 |
| 142 | positive regulation of interferon-alpha production (GO:0032727) | 2.79126151 |
| 143 | cytidine catabolic process (GO:0006216) | 2.78891646 |
| 144 | cytidine deamination (GO:0009972) | 2.78891646 |
| 145 | cytidine metabolic process (GO:0046087) | 2.78891646 |
| 146 | low-density lipoprotein particle remodeling (GO:0034374) | 2.78764221 |
| 147 | cellular response to zinc ion (GO:0071294) | 2.78728924 |
| 148 | regulation of interleukin-8 secretion (GO:2000482) | 2.76928185 |
| 149 | digestion (GO:0007586) | 2.76789360 |
| 150 | regulation of cholesterol storage (GO:0010885) | 2.76661716 |
| 151 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.75745448 |
| 152 | xenobiotic catabolic process (GO:0042178) | 2.75077342 |
| 153 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.74081004 |
| 154 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.74016518 |
| 155 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.73481847 |
| 156 | arginine metabolic process (GO:0006525) | 2.73157067 |
| 157 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.73049686 |
| 158 | regulation of podosome assembly (GO:0071801) | 2.72723781 |
| 159 | positive regulation of lipid catabolic process (GO:0050996) | 2.72083953 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.70858919 |
| 161 | granulocyte activation (GO:0036230) | 2.70784654 |
| 162 | plasma lipoprotein particle organization (GO:0071827) | 2.69733378 |
| 163 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.67681147 |
| 164 | immunoglobulin mediated immune response (GO:0016064) | 2.65843143 |
| 165 | protein-lipid complex subunit organization (GO:0071825) | 2.65837789 |
| 166 | neutrophil activation (GO:0042119) | 2.65791104 |
| 167 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.64727554 |
| 168 | regulation of monocyte chemotaxis (GO:0090025) | 2.62929334 |
| 169 | glyoxylate metabolic process (GO:0046487) | 2.62243430 |
| 170 | negative regulation of cholesterol transport (GO:0032375) | 2.61374078 |
| 171 | negative regulation of sterol transport (GO:0032372) | 2.61374078 |
| 172 | glutathione metabolic process (GO:0006749) | 2.60273450 |
| 173 | positive regulation of hemostasis (GO:1900048) | 2.60227599 |
| 174 | positive regulation of blood coagulation (GO:0030194) | 2.60227599 |
| 175 | regulation of interferon-alpha production (GO:0032647) | 2.58577668 |
| 176 | response to fungus (GO:0009620) | 2.55973823 |
| 177 | L-phenylalanine metabolic process (GO:0006558) | 2.54111519 |
| 178 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.54111519 |
| 179 | amyloid precursor protein catabolic process (GO:0042987) | 2.51362143 |
| 180 | complement activation, alternative pathway (GO:0006957) | 2.51248735 |
| 181 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51130525 |
| 182 | fructose metabolic process (GO:0006000) | 2.51061037 |
| 183 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48297711 |
| 184 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47714258 |
| 185 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.47593382 |
| 186 | endosome to pigment granule transport (GO:0043485) | 2.47468346 |
| 187 | endosome to melanosome transport (GO:0035646) | 2.47468346 |
| 188 | regulation of mononuclear cell migration (GO:0071675) | 2.46918011 |
| 189 | cellular response to exogenous dsRNA (GO:0071360) | 2.45862365 |
| 190 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45567557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.93815862 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.91354793 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.67274699 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.37493047 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.15306355 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.93594317 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67298182 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.38189743 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24722697 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.22504459 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.14173376 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.02074373 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.00797885 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.94271396 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93293210 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87110966 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.67298624 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.61089364 |
| 19 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58015938 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.55929700 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.54182281 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.48607505 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40370060 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37218775 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.35244689 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31723538 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.30772533 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26084642 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.22367142 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19364086 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15801376 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.14337641 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.13851892 |
| 34 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.07726831 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06101463 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99209850 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92714755 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77967353 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.76734373 |
| 40 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75942937 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74102007 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71381210 |
| 43 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.69491577 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.68297375 |
| 45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67134351 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66084126 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64417086 |
| 48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64073140 |
| 49 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.62830201 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59806373 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58118913 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56853952 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55694134 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55629318 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54176094 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.54003447 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53837006 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53398496 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52287345 |
| 60 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50904586 |
| 61 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.44865818 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44641953 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44167382 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43491101 |
| 65 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41535031 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41340726 |
| 67 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.40325545 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40281939 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.40256993 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39903944 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39793029 |
| 72 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.38622018 |
| 73 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33937635 |
| 74 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30175411 |
| 75 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30175411 |
| 76 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29815196 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29713984 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29515071 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28648099 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28291526 |
| 81 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25986671 |
| 82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24815139 |
| 83 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.24127341 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23462364 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23298066 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23282855 |
| 87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20555194 |
| 88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20168623 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17837780 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17769862 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17102835 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16904473 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15605636 |
| 94 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15390649 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13925586 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13368993 |
| 97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12975861 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12503572 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12470628 |
| 100 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11986428 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11738761 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09314815 |
| 103 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08907116 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.08142624 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08103320 |
| 106 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07581485 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07190711 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06147927 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05892937 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05733958 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02754692 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00583310 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99719775 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99544563 |
| 115 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99110046 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97366912 |
| 117 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97217133 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96999080 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96443938 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94815215 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94579615 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.92719122 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92463046 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91627802 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91627802 |
| 126 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.90578042 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89863490 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 0.89536128 |
| 129 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89229451 |
| 130 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88841020 |
| 131 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87938737 |
| 132 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87938737 |
| 133 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87162281 |
| 134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87151491 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86852897 |
| 136 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86148474 |
| 137 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.84226514 |
| 138 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83227818 |
| 139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82345986 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81333914 |
| 141 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81198254 |
| 142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80760780 |
| 143 | MAF_26560356_Chip-Seq_TH1_Human | 0.80443844 |
| 144 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80236880 |
| 145 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79735716 |
| 146 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.79607130 |
| 147 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.79379848 |
| 148 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79193091 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78658968 |
| 150 | UTX_26944678_Chip-Seq_JUKART_Human | 0.78649431 |
| 151 | SPI1_23127762_ChIP-Seq_K562_Human | 0.78419945 |
| 152 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.78397932 |
| 153 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77290754 |
| 154 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77243069 |
| 155 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.77132788 |
| 156 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.76916500 |
| 157 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.76349799 |
| 158 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.76191702 |
| 159 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74854659 |
| 160 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74280906 |
| 161 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74279804 |
| 162 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73369013 |
| 163 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72774661 |
| 164 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71442438 |
| 165 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70160421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.64775007 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.26665796 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.76501625 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.65839578 |
| 5 | MP0003436_decreased_susceptibility_to | 3.54909663 |
| 6 | MP0002938_white_spotting | 3.32308350 |
| 7 | MP0004043_abnormal_pH_regulation | 3.08187648 |
| 8 | MP0009840_abnormal_foam_cell | 3.01639374 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.96759322 |
| 10 | MP0009785_altered_susceptibility_to | 2.96488590 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.87103873 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.81616948 |
| 13 | MP0006082_CNS_inflammation | 2.65067056 |
| 14 | MP0003868_abnormal_feces_composition | 2.61047873 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.51069638 |
| 16 | MP0002254_reproductive_system_inflammat | 2.48990087 |
| 17 | MP0001664_abnormal_digestion | 2.41837176 |
| 18 | MP0002419_abnormal_innate_immunity | 2.32142982 |
| 19 | MP0005670_abnormal_white_adipose | 2.32126323 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.30018849 |
| 21 | MP0003252_abnormal_bile_duct | 2.27546942 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.17988879 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.17227567 |
| 24 | MP0005025_abnormal_response_to | 2.12536169 |
| 25 | MP0001765_abnormal_ion_homeostasis | 1.98859950 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.95674045 |
| 27 | MP0003724_increased_susceptibility_to | 1.94550098 |
| 28 | MP0004147_increased_porphyrin_level | 1.93348316 |
| 29 | MP0003303_peritoneal_inflammation | 1.89413485 |
| 30 | MP0000566_synostosis | 1.88721304 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.88226726 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.85203983 |
| 33 | MP0002796_impaired_skin_barrier | 1.82799795 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.80824482 |
| 35 | MP0003186_abnormal_redox_activity | 1.72392775 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.71497682 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.71296051 |
| 38 | MP0001873_stomach_inflammation | 1.68515024 |
| 39 | MP0005671_abnormal_response_to | 1.68415837 |
| 40 | MP0009764_decreased_sensitivity_to | 1.66617302 |
| 41 | MP0002723_abnormal_immune_serum | 1.65330083 |
| 42 | MP0001853_heart_inflammation | 1.64387469 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.61539696 |
| 44 | MP0001800_abnormal_humoral_immune | 1.58799594 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.58590823 |
| 46 | MP0008469_abnormal_protein_level | 1.56187924 |
| 47 | MP0005365_abnormal_bile_salt | 1.56053007 |
| 48 | MP0000343_altered_response_to | 1.53664952 |
| 49 | MP0003075_altered_response_to | 1.50265039 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.49075404 |
| 51 | MP0005381_digestive/alimentary_phenotyp | 1.48074179 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.47707705 |
| 53 | MP0001819_abnormal_immune_cell | 1.46312223 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.45017000 |
| 55 | MP0002098_abnormal_vibrissa_morphology | 1.43454364 |
| 56 | MP0004510_myositis | 1.42108282 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.41838566 |
| 58 | MP0003195_calcinosis | 1.41772922 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.41629584 |
| 60 | MP0004883_abnormal_blood_vessel | 1.40846880 |
| 61 | MP0005332_abnormal_amino_acid | 1.40419231 |
| 62 | MP0005166_decreased_susceptibility_to | 1.40199379 |
| 63 | MP0001790_abnormal_immune_system | 1.38647756 |
| 64 | MP0005387_immune_system_phenotype | 1.38647756 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.38608348 |
| 66 | MP0002405_respiratory_system_inflammati | 1.38112167 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.37711584 |
| 68 | MP0005501_abnormal_skin_physiology | 1.29998097 |
| 69 | MP0000678_abnormal_parathyroid_gland | 1.29573998 |
| 70 | MP0000609_abnormal_liver_physiology | 1.28762455 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.27957582 |
| 72 | MP0000685_abnormal_immune_system | 1.26330831 |
| 73 | MP0005164_abnormal_response_to | 1.25968024 |
| 74 | MP0004947_skin_inflammation | 1.25105753 |
| 75 | MP0000858_altered_metastatic_potential | 1.22092973 |
| 76 | MP0003690_abnormal_glial_cell | 1.21803911 |
| 77 | MP0009697_abnormal_copulation | 1.07629492 |
| 78 | MP0001663_abnormal_digestive_system | 1.07361971 |
| 79 | MP0000462_abnormal_digestive_system | 1.06595099 |
| 80 | MP0009763_increased_sensitivity_to | 1.06485907 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.04244224 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.03333481 |
| 83 | MP0005451_abnormal_body_composition | 1.02220213 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 1.00998875 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.98053277 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.97344829 |
| 87 | MP0010678_abnormal_skin_adnexa | 0.97204398 |
| 88 | MP0000490_abnormal_crypts_of | 0.95941029 |
| 89 | MP0000467_abnormal_esophagus_morphology | 0.95839719 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 0.94951774 |
| 91 | MP0002932_abnormal_joint_morphology | 0.93783479 |
| 92 | MP0005408_hypopigmentation | 0.93327046 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.91509813 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.91113024 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90836882 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.89998878 |
| 97 | MP0009379_abnormal_foot_pigmentation | 0.89538212 |
| 98 | MP0005083_abnormal_biliary_tract | 0.88524766 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.87770693 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.86898623 |
| 101 | MP0002006_tumorigenesis | 0.86895077 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.85825782 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.85209883 |
| 104 | MP0000716_abnormal_immune_system | 0.84986453 |
| 105 | MP0000537_abnormal_urethra_morphology | 0.83954834 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.82737008 |
| 107 | MP0003448_altered_tumor_morphology | 0.82329926 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.81932494 |
| 109 | MP0008872_abnormal_physiological_respon | 0.81152501 |
| 110 | MP0000598_abnormal_liver_morphology | 0.79958469 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.79629810 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.78911308 |
| 113 | MP0005310_abnormal_salivary_gland | 0.76700714 |
| 114 | MP0000249_abnormal_blood_vessel | 0.75833696 |
| 115 | MP0003828_pulmonary_edema | 0.75767942 |
| 116 | MP0008004_abnormal_stomach_pH | 0.75473832 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.74954878 |
| 118 | MP0001764_abnormal_homeostasis | 0.73720863 |
| 119 | MP0001756_abnormal_urination | 0.73588961 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.73150184 |
| 121 | MP0002876_abnormal_thyroid_physiology | 0.72322942 |
| 122 | MP0003718_maternal_effect | 0.71221397 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.71030541 |
| 124 | MP0003879_abnormal_hair_cell | 0.70990305 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.70925111 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.70861184 |
| 127 | MP0000604_amyloidosis | 0.70416111 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.69555709 |
| 129 | MP0003866_abnormal_defecation | 0.69438112 |
| 130 | MP0002132_abnormal_respiratory_system | 0.68855523 |
| 131 | MP0002822_catalepsy | 0.68517452 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.68309486 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.68098614 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.67897497 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.67354191 |
| 136 | MP0002429_abnormal_blood_cell | 0.67281727 |
| 137 | MP0001851_eye_inflammation | 0.64142072 |
| 138 | MP0002877_abnormal_melanocyte_morpholog | 0.64010076 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.63214182 |
| 140 | MP0002396_abnormal_hematopoietic_system | 0.63012644 |
| 141 | MP0005076_abnormal_cell_differentiation | 0.63006601 |
| 142 | MP0004185_abnormal_adipocyte_glucose | 0.61884011 |
| 143 | MP0003941_abnormal_skin_development | 0.61284570 |
| 144 | MP0006036_abnormal_mitochondrial_physio | 0.57223287 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.56790180 |
| 146 | MP0004858_abnormal_nervous_system | 0.54842574 |
| 147 | MP0001881_abnormal_mammary_gland | 0.53925647 |
| 148 | MP0000470_abnormal_stomach_morphology | 0.50859965 |
| 149 | MP0000377_abnormal_hair_follicle | 0.50016261 |
| 150 | MP0010771_integument_phenotype | 0.48939243 |
| 151 | MP0005266_abnormal_metabolism | 0.48892499 |
| 152 | MP0005165_increased_susceptibility_to | 0.48507497 |
| 153 | MP0002249_abnormal_larynx_morphology | 0.48301201 |
| 154 | MP0001849_ear_inflammation | 0.47463282 |
| 155 | MP0003953_abnormal_hormone_level | 0.47440637 |
| 156 | MP0000627_abnormal_mammary_gland | 0.46935286 |
| 157 | MP0002971_abnormal_brown_adipose | 0.46845920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 8.69823591 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.11467128 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.97320098 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.66284068 |
| 5 | Abnormality of renin-angiotensin system (HP:0000847) | 5.51026662 |
| 6 | Eczematoid dermatitis (HP:0000976) | 5.29102893 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.06579207 |
| 8 | Decreased circulating renin level (HP:0003351) | 4.88381598 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.60656442 |
| 10 | Alkalosis (HP:0001948) | 4.31377428 |
| 11 | Abnormality of chloride homeostasis (HP:0011422) | 4.22967937 |
| 12 | Hyperaldosteronism (HP:0000859) | 4.09959718 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.06557310 |
| 14 | Axonal loss (HP:0003447) | 4.06161597 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 3.80982519 |
| 16 | Ileus (HP:0002595) | 3.77693768 |
| 17 | Abdominal distention (HP:0003270) | 3.70241610 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.68748241 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.65661832 |
| 20 | Flat acetabular roof (HP:0003180) | 3.61813285 |
| 21 | Xanthomatosis (HP:0000991) | 3.59508753 |
| 22 | Recurrent skin infections (HP:0001581) | 3.47126755 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.42883588 |
| 24 | Nausea (HP:0002018) | 3.41611546 |
| 25 | Abnormality of complement system (HP:0005339) | 3.40276721 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39833938 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.38540519 |
| 28 | Joint hemorrhage (HP:0005261) | 3.37036762 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.34444829 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.32662656 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.32662656 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.29962968 |
| 33 | Stenosis of the external auditory canal (HP:0000402) | 3.20868308 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19343154 |
| 35 | Obstructive lung disease (HP:0006536) | 3.19343154 |
| 36 | Deep venous thrombosis (HP:0002625) | 3.10899045 |
| 37 | Gingivitis (HP:0000230) | 3.03686748 |
| 38 | Hyponatremia (HP:0002902) | 3.01887684 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 3.01784255 |
| 40 | Complement deficiency (HP:0004431) | 2.99635408 |
| 41 | Glomerulonephritis (HP:0000099) | 2.98378039 |
| 42 | Orchitis (HP:0100796) | 2.98354458 |
| 43 | Myocardial infarction (HP:0001658) | 2.97028038 |
| 44 | Macrocytic anemia (HP:0001972) | 2.93494823 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.91693309 |
| 46 | Palpitations (HP:0001962) | 2.88798464 |
| 47 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.83654527 |
| 48 | Confusion (HP:0001289) | 2.79680320 |
| 49 | Hypercholesterolemia (HP:0003124) | 2.79418925 |
| 50 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.78516639 |
| 51 | Impaired platelet aggregation (HP:0003540) | 2.77448363 |
| 52 | Abnormal platelet function (HP:0011869) | 2.77448363 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76327804 |
| 54 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73241204 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.71468409 |
| 56 | Pustule (HP:0200039) | 2.71372529 |
| 57 | Myositis (HP:0100614) | 2.70820700 |
| 58 | Epidermoid cyst (HP:0200040) | 2.70532266 |
| 59 | Menorrhagia (HP:0000132) | 2.70212354 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.69471853 |
| 61 | Amyloidosis (HP:0011034) | 2.63523804 |
| 62 | Focal segmental glomerulosclerosis (HP:0000097) | 2.63344900 |
| 63 | Nephritis (HP:0000123) | 2.61658844 |
| 64 | Pili torti (HP:0003777) | 2.61383931 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.61122569 |
| 66 | Abnormality of vitamin B metabolism (HP:0004340) | 2.57473972 |
| 67 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.57223281 |
| 68 | Colitis (HP:0002583) | 2.55108260 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.51765250 |
| 70 | Cellulitis (HP:0100658) | 2.51568028 |
| 71 | Hypokalemia (HP:0002900) | 2.51032541 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 2.49277518 |
| 73 | Urticaria (HP:0001025) | 2.47830779 |
| 74 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47442203 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47244733 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47244733 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47244733 |
| 78 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.46522760 |
| 79 | Villous atrophy (HP:0011473) | 2.46522760 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 2.45979832 |
| 81 | Malnutrition (HP:0004395) | 2.44688036 |
| 82 | Abnormal hair laboratory examination (HP:0003328) | 2.44083083 |
| 83 | Hypolipoproteinemia (HP:0010981) | 2.44066464 |
| 84 | Hematochezia (HP:0002573) | 2.43452125 |
| 85 | Prolonged partial thromboplastin time (HP:0003645) | 2.42978720 |
| 86 | Stomatitis (HP:0010280) | 2.42278830 |
| 87 | Renal tubular acidosis (HP:0001947) | 2.40650118 |
| 88 | Meningitis (HP:0001287) | 2.37057616 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.34924829 |
| 90 | Glycosuria (HP:0003076) | 2.34924829 |
| 91 | Abnormality of potassium homeostasis (HP:0011042) | 2.32552503 |
| 92 | Vasculitis (HP:0002633) | 2.31053951 |
| 93 | Prostate neoplasm (HP:0100787) | 2.27990788 |
| 94 | Petechiae (HP:0000967) | 2.26663649 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26578934 |
| 96 | Spinal cord compression (HP:0002176) | 2.25905606 |
| 97 | Epistaxis (HP:0000421) | 2.23732061 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.23263996 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.23263996 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20991752 |
| 101 | Widely patent fontanelles and sutures (HP:0004492) | 2.20717048 |
| 102 | Congenital, generalized hypertrichosis (HP:0004540) | 2.20218495 |
| 103 | Upper motor neuron abnormality (HP:0002127) | 2.20094665 |
| 104 | Abnormal vertebral ossification (HP:0100569) | 2.19079184 |
| 105 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18779641 |
| 106 | Renal tubular dysfunction (HP:0000124) | 2.17113998 |
| 107 | Hepatosplenomegaly (HP:0001433) | 2.16889280 |
| 108 | Curly hair (HP:0002212) | 2.15696633 |
| 109 | Megaloblastic anemia (HP:0001889) | 2.14960247 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.14791494 |
| 111 | Dehydration (HP:0001944) | 2.14494429 |
| 112 | Hypoalphalipoproteinemia (HP:0003233) | 2.14178183 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 2.13458717 |
| 114 | Increased cerebral lipofuscin (HP:0011813) | 2.11876680 |
| 115 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11675488 |
| 116 | Abnormal platelet volume (HP:0011876) | 2.10496564 |
| 117 | Vascular calcification (HP:0004934) | 2.10374792 |
| 118 | Chronic bronchitis (HP:0004469) | 2.10197579 |
| 119 | Hyperammonemia (HP:0001987) | 2.10137095 |
| 120 | Fat malabsorption (HP:0002630) | 2.09931065 |
| 121 | Abnormality of proline metabolism (HP:0010907) | 2.09309040 |
| 122 | Hydroxyprolinuria (HP:0003080) | 2.09309040 |
| 123 | Bone cyst (HP:0012062) | 2.08809470 |
| 124 | Glomerulosclerosis (HP:0000096) | 2.07299108 |
| 125 | Dysostosis multiplex (HP:0000943) | 2.06682421 |
| 126 | Increased serum ferritin (HP:0003281) | 2.05246109 |
| 127 | Esophageal neoplasm (HP:0100751) | 2.04835864 |
| 128 | Neoplasm of head and neck (HP:0012288) | 2.04835864 |
| 129 | Metabolic acidosis (HP:0001942) | 2.04294409 |
| 130 | Cerebral palsy (HP:0100021) | 2.03349063 |
| 131 | Gingival bleeding (HP:0000225) | 2.02173412 |
| 132 | Increased mean platelet volume (HP:0011877) | 2.01201240 |
| 133 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.01163149 |
| 134 | Posterior subcapsular cataract (HP:0007787) | 2.01146217 |
| 135 | Abnormality of sodium homeostasis (HP:0010931) | 2.01144201 |
| 136 | Cheilitis (HP:0100825) | 2.00946651 |
| 137 | Osteomyelitis (HP:0002754) | 2.00140127 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00100145 |
| 139 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00100145 |
| 140 | Abnormality of carpal bone ossification (HP:0006257) | 1.99328513 |
| 141 | Peritonitis (HP:0002586) | 1.98983722 |
| 142 | Optic neuritis (HP:0100653) | 1.97919073 |
| 143 | Retrobulbar optic neuritis (HP:0100654) | 1.97919073 |
| 144 | Woolly hair (HP:0002224) | 1.97535063 |
| 145 | Abnormal tarsal ossification (HP:0008369) | 1.96640548 |
| 146 | Abnormality of iron homeostasis (HP:0011031) | 1.96360011 |
| 147 | Neonatal short-limb short stature (HP:0008921) | 1.96263911 |
| 148 | Adrenal overactivity (HP:0002717) | 1.96244856 |
| 149 | Hyperlipoproteinemia (HP:0010980) | 1.96201894 |
| 150 | Abnormal urine phosphate concentration (HP:0012599) | 1.95613342 |
| 151 | Hoarse voice (HP:0001609) | 1.95232823 |
| 152 | Abnormality of purine metabolism (HP:0004352) | 1.94945564 |
| 153 | Purpura (HP:0000979) | 1.94601176 |
| 154 | Partial duplication of thumb phalanx (HP:0009944) | 1.94258853 |
| 155 | Chronic diarrhea (HP:0002028) | 1.93985882 |
| 156 | Basal ganglia calcification (HP:0002135) | 1.93980726 |
| 157 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93808236 |
| 158 | Flattened epiphyses (HP:0003071) | 1.93252952 |
| 159 | Inflammation of the large intestine (HP:0002037) | 1.92875727 |
| 160 | Micronodular cirrhosis (HP:0001413) | 1.92658534 |
| 161 | Syncope (HP:0001279) | 1.92201406 |
| 162 | Hyperparathyroidism (HP:0000843) | 1.91348623 |
| 163 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90384743 |
| 164 | Hyperuricemia (HP:0002149) | 1.90350912 |
| 165 | Increased purine levels (HP:0004368) | 1.90350912 |
| 166 | Pancreatitis (HP:0001733) | 1.89892071 |
| 167 | Hypoglycemic coma (HP:0001325) | 1.89179440 |
| 168 | Disinhibition (HP:0000734) | 1.88373367 |
| 169 | Hemoptysis (HP:0002105) | 1.88259640 |
| 170 | Hyperphosphaturia (HP:0003109) | 1.87518922 |
| 171 | Increased muscle lipid content (HP:0009058) | 1.87292424 |
| 172 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.86760019 |
| 173 | Hyperkalemia (HP:0002153) | 1.86113650 |
| 174 | Gout (HP:0001997) | 1.84520099 |
| 175 | Abnormal biliary tract morphology (HP:0012440) | 1.83970689 |
| 176 | Flat capital femoral epiphysis (HP:0003370) | 1.83793717 |
| 177 | Conjunctival hamartoma (HP:0100780) | 1.79431282 |
| 178 | Late onset (HP:0003584) | 1.78841473 |
| 179 | Pigmentary retinal degeneration (HP:0001146) | 1.78678285 |
| 180 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77884531 |
| 181 | Increased intramyocellular lipid droplets (HP:0012240) | 1.76202062 |
| 182 | Abnormality of the vocal cords (HP:0008777) | 1.73359435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.91769432 |
| 2 | LMTK2 | 4.85934996 |
| 3 | ERN1 | 3.71720261 |
| 4 | NME2 | 3.66912889 |
| 5 | ACVR1B | 3.35581365 |
| 6 | MAP3K14 | 3.29496059 |
| 7 | MET | 3.28180835 |
| 8 | MAP3K10 | 3.28030511 |
| 9 | TYK2 | 3.20742452 |
| 10 | PDK2 | 3.20157562 |
| 11 | ARAF | 3.15182572 |
| 12 | PIK3CA | 3.14595540 |
| 13 | PIM2 | 2.95578964 |
| 14 | IRAK3 | 2.86904638 |
| 15 | MAP4K1 | 2.50183914 |
| 16 | STK39 | 2.48006597 |
| 17 | IRAK4 | 2.45475526 |
| 18 | RIPK4 | 2.39989786 |
| 19 | NEK9 | 2.34361253 |
| 20 | SIK1 | 2.27127914 |
| 21 | BLK | 2.26412793 |
| 22 | CASK | 2.00332882 |
| 23 | CLK1 | 1.98203885 |
| 24 | RIPK1 | 1.95023277 |
| 25 | TBK1 | 1.92213539 |
| 26 | RPS6KB2 | 1.80056429 |
| 27 | IKBKB | 1.78727215 |
| 28 | STK24 | 1.75385378 |
| 29 | KIT | 1.60079360 |
| 30 | MAP3K11 | 1.53940193 |
| 31 | MYLK | 1.53109411 |
| 32 | JAK1 | 1.51405485 |
| 33 | MST4 | 1.48324191 |
| 34 | ABL2 | 1.47826876 |
| 35 | MATK | 1.45314029 |
| 36 | MST1R | 1.40014125 |
| 37 | PKN2 | 1.39005402 |
| 38 | IKBKE | 1.37868008 |
| 39 | OXSR1 | 1.34082204 |
| 40 | FLT3 | 1.32564688 |
| 41 | BRSK2 | 1.32027875 |
| 42 | TXK | 1.29383366 |
| 43 | TEC | 1.28463963 |
| 44 | MAP2K2 | 1.27334308 |
| 45 | MAP3K13 | 1.25014947 |
| 46 | CSK | 1.21666752 |
| 47 | CSF1R | 1.17593289 |
| 48 | PBK | 1.15767900 |
| 49 | TAOK2 | 1.14031334 |
| 50 | PHKG2 | 1.07676125 |
| 51 | PHKG1 | 1.07676125 |
| 52 | MOS | 1.07063355 |
| 53 | BMPR2 | 1.06737838 |
| 54 | RPS6KA4 | 1.05329047 |
| 55 | TGFBR2 | 1.01625083 |
| 56 | EPHB2 | 0.98249128 |
| 57 | JAK2 | 0.97565199 |
| 58 | PIM1 | 0.96097343 |
| 59 | PRKCI | 0.95451010 |
| 60 | IRAK1 | 0.95308838 |
| 61 | TESK2 | 0.93300150 |
| 62 | CHUK | 0.93227814 |
| 63 | MAP3K12 | 0.90536755 |
| 64 | PRKG2 | 0.89695515 |
| 65 | MAP3K2 | 0.88406134 |
| 66 | SYK | 0.88344868 |
| 67 | JAK3 | 0.88206453 |
| 68 | KSR2 | 0.87456772 |
| 69 | LYN | 0.87130261 |
| 70 | BTK | 0.86005335 |
| 71 | PTK2 | 0.85165680 |
| 72 | BMX | 0.84869428 |
| 73 | GRK6 | 0.81045741 |
| 74 | GRK7 | 0.80720390 |
| 75 | TESK1 | 0.80374369 |
| 76 | YES1 | 0.80271229 |
| 77 | HCK | 0.79266996 |
| 78 | ZAP70 | 0.79237679 |
| 79 | CDK9 | 0.73048015 |
| 80 | BRAF | 0.71703448 |
| 81 | CAMK2D | 0.71039274 |
| 82 | MAP3K1 | 0.70427935 |
| 83 | DDR2 | 0.70133445 |
| 84 | CAMK2G | 0.69517729 |
| 85 | FRK | 0.67892536 |
| 86 | GRK1 | 0.67754645 |
| 87 | PDPK1 | 0.67193908 |
| 88 | PDK1 | 0.66795005 |
| 89 | PTK6 | 0.66482609 |
| 90 | AURKB | 0.66082128 |
| 91 | CDK6 | 0.61217561 |
| 92 | TAOK3 | 0.60401144 |
| 93 | BMPR1B | 0.59709140 |
| 94 | WNK4 | 0.59371847 |
| 95 | MAP3K3 | 0.58198464 |
| 96 | ICK | 0.57970219 |
| 97 | MAP2K6 | 0.55132491 |
| 98 | FGR | 0.54967133 |
| 99 | EIF2AK1 | 0.54795828 |
| 100 | EPHB1 | 0.52796351 |
| 101 | MAP3K8 | 0.52061920 |
| 102 | CAMK2B | 0.50320978 |
| 103 | NEK1 | 0.48716989 |
| 104 | LCK | 0.48568139 |
| 105 | EIF2AK2 | 0.48288477 |
| 106 | PRKCD | 0.47011148 |
| 107 | PAK4 | 0.46226298 |
| 108 | NEK6 | 0.45560401 |
| 109 | RPS6KA6 | 0.45396268 |
| 110 | PRKAA2 | 0.44547332 |
| 111 | ERBB4 | 0.43526283 |
| 112 | LATS2 | 0.42565956 |
| 113 | RPS6KC1 | 0.42221384 |
| 114 | RPS6KL1 | 0.42221384 |
| 115 | ZAK | 0.41085506 |
| 116 | MAPKAPK3 | 0.40941678 |
| 117 | RAF1 | 0.40702263 |
| 118 | AKT2 | 0.40390917 |
| 119 | MAP3K7 | 0.39945905 |
| 120 | MAP2K1 | 0.39005091 |
| 121 | BCKDK | 0.38883835 |
| 122 | ABL1 | 0.38738573 |
| 123 | DAPK1 | 0.38733750 |
| 124 | MAPK7 | 0.37921188 |
| 125 | IRAK2 | 0.35822751 |
| 126 | HIPK2 | 0.35537868 |
| 127 | PRKCQ | 0.34770625 |
| 128 | MAP2K3 | 0.34699272 |
| 129 | ITK | 0.33534442 |
| 130 | MAPK4 | 0.33402311 |
| 131 | PRKCA | 0.31065856 |
| 132 | TTK | 0.27875881 |
| 133 | ILK | 0.27468637 |
| 134 | MAPKAPK2 | 0.26509307 |
| 135 | CDC7 | 0.26221966 |
| 136 | NLK | 0.25925298 |
| 137 | MAP3K5 | 0.25663231 |
| 138 | DYRK1B | 0.25371366 |
| 139 | CSNK1A1 | 0.25009233 |
| 140 | TAOK1 | 0.24629053 |
| 141 | RPS6KA2 | 0.24543083 |
| 142 | STK3 | 0.24361337 |
| 143 | MAPK12 | 0.24331215 |
| 144 | ERBB2 | 0.24169039 |
| 145 | EGFR | 0.23387147 |
| 146 | PLK1 | 0.22297307 |
| 147 | PRKCE | 0.21769961 |
| 148 | AURKA | 0.20947985 |
| 149 | MELK | 0.20679890 |
| 150 | SRC | 0.19743276 |
| 151 | CSNK2A2 | 0.18734682 |
| 152 | BRSK1 | 0.18693692 |
| 153 | CDK3 | 0.17520595 |
| 154 | VRK2 | 0.15962485 |
| 155 | CSNK1E | 0.14904176 |
| 156 | STK16 | 0.14882610 |
| 157 | SMG1 | 0.14762779 |
| 158 | PRKACG | 0.14265070 |
| 159 | SGK1 | 0.12864650 |
| 160 | SCYL2 | 0.12762138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.97339095 |
| 2 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.55152180 |
| 3 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.17603599 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.89904443 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.82759897 |
| 6 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.82111633 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.72938802 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.47897190 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01901373 |
| 10 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.99024965 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93904808 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.90581808 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85337989 |
| 14 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.79483168 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.76484262 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.75778252 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74138916 |
| 18 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71329844 |
| 19 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67709745 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56409415 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.51104084 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.49689740 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42424554 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40976794 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38789904 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38639371 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36782903 |
| 28 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.36565576 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36393720 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.33710423 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31988576 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.30783815 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.30197578 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29253610 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.29221426 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28891957 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27632642 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25171432 |
| 39 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22579819 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22478893 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.19739057 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17513522 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16428973 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13893049 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.11774991 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10847680 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.08361222 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06116042 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05204976 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03013911 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02447606 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.98315766 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98185445 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.97364311 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95156540 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93616773 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91275631 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90845730 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89633934 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89622467 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88150695 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86899466 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.82126795 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 0.82079200 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79717672 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79712289 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77520212 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77427333 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.77173175 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 0.76549447 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75983412 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75781006 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74393377 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73578442 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71046125 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70339415 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70296358 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68919630 |
| 79 | Protein export_Homo sapiens_hsa03060 | 0.68747240 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67649689 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67269371 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66881964 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66481685 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65216896 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64410533 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62984373 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61520226 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58920198 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58264540 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56867361 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56693530 |
| 92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55654761 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55582092 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54886395 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.54212679 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53957291 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53890815 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53318791 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53038993 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52334913 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52230265 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.51762443 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51440746 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51370791 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50459640 |
| 106 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50224388 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49505644 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48872397 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48307544 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.47530250 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.45424786 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44915401 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.43908877 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43229133 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42822184 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42366167 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41805693 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.40905407 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40634498 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39929246 |
| 121 | DNA replication_Homo sapiens_hsa03030 | 0.39914725 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38756620 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37726925 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34087181 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.29101892 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25477291 |
| 127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24327501 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21483867 |
| 129 | Base excision repair_Homo sapiens_hsa03410 | 0.21455602 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.19330765 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18833421 |
| 132 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17614782 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.14929218 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14461289 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.10605585 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09302475 |
| 137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.06709147 |
| 138 | Homologous recombination_Homo sapiens_hsa03440 | 0.03640727 |
| 139 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03339653 |

